Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety survey of Bevacizumab BS "Daiichi Sankyo" using EBM Provider
jRCT2031220643Recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of bevacizumab in colon cancer and rectal cancer (2 cohorts), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Occurrence of hypertension. Started Apr 2008; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
colon cancerrectal cancer
Beyond the preview
Go deeper on jRCT2031220643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220643.